SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Human Genome Sciences, Inc. (HGSI)
An SI Board Since March 1996
Posts SubjectMarks Bans Symbol
1127 105 0 HGSI
Emcee:  Jeffrey Ogbar Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
927HGS Signs Albuferon Deal With Novartis Worth Up To $550M By Aaron Lorenzo Washbob zagorin-6/8/2006
926more detail on novartis xml.10kwizard.combob zagorin-6/8/2006
925Novartis Secures License Rights To Experimental Hepatitis Drug By SCOTT HENSLEY bob zagorin-6/8/2006
924from zacks... EPS Estimate Revisions Symbol Broker Revision Period Period Ebob zagorin-6/7/2006
923ML just raised hgsi to buy. meanwhile this from GS "...Human Genome Sciencbob zagorin-6/6/2006
922Human Genome Sciences Announces Collaboration with Novartis for Development and nigel bates-6/6/2006
921Human Genome Sciences Announces Results for First Quarter of 2006 Wednesday May bob zagorin-5/10/2006
920Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at bob zagorin-5/5/2006
919dj reporting that hgsi is selling rockville property to realty trust for $425m abob zagorin-5/2/2006
918As posted on the Yahoo board: << 01-May-06 07:14 ET In Play EarlyResearchSteven Rachbach-5/1/2006
917also heard that hgsi got an upgrade this morning but so far i cant find it..bob zagorin-5/1/2006
916Human Genome Sciences Presents Interim Results of Phase 2 Trial of Albuferon(TM)bob zagorin-5/1/2006
915bizjournals.com MedImmune to invest in N.J. biotech Monday April 24, 1:05 pm ET bob zagorin-4/24/2006
914UPGRADES & DOWNGRADES HISTORY Date Research Firm Action From To 18-Apbob zagorin-4/18/2006
913GS on HGSI Human Genome Sciences, Inc. EPS (FY Dec) 2006E ($2.17), 2007E ($2.26bob zagorin-3/24/2006
912proxy xml.10kwizard.combob zagorin-3/22/2006
911more from forbes Human Genome Sciences Seen Partnering Hep C Drug In 2006 Peterbob zagorin-3/16/2006
910from barrons online "...The biopharmaceutical company's stock plunged bob zagorin-3/16/2006
909Forbes.com Market Scan Human Genome's Trial Data Builds Confidence On Wall bob zagorin-3/15/2006
908I had a chance to look at the numbers. Basically, the results speak for themselvSteven Rachbach-3/15/2006
907piper jaffrey just increased target from 15 to 20....bob zagorin-3/14/2006
906Human Genome Sciences Reports Positive Interim Results of Phase 2 Trial of Albufnigel bates-3/14/2006
905i sold my hgsi about a week for good gain but missed this last run. any opinionsbob zagorin-3/2/2006
904Human Genome Sciences (HGSI) : Cuts to 2 STARS (sell) from 3 STARS (hold) S&Doc Bones-2/10/2006
903Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at bob zagorin-2/3/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News